Omega Fund Management, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$222.4B
Holdings
12
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (12 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KMTSKestra Med Technologies Ltd | 1,645,893 | $39.1B | 17.59% | |
| 2 | BBNXBeta Bionics Inc. | 1,920,125 | $38.2B | 17.16% | |
| 3 | BBOTBridgeBio Oncology Therapeutics Inc. | 3,289,661 | $38.1B | 17.13% | |
| 4 | BCAXBicara Therapeutics Inc. | 2,204,650 | $34.8B | 15.66% | |
| 5 | NUVBNuvation Bio | 8,831,089 | $32.7B | 14.69% | |
| 6 | UPBUpstream Bio Inc. | 1,356,293 | $25.5B | 11.47% | |
| 7 | IMAImageneBio, Inc. | 455,361 | $3.7B | 1.67% | |
| 8 | ENGNenGene Holdings Inc. | 526,357 | $3.6B | 1.62% | |
| 9 | SANASana Biotechnology, Inc. | 843,750 | $3.0B | 1.35% | |
| 10 | ALMSAlumis Inc. | 653,223 | $2.6B | 1.17% | |
| 11 | REPLReplimune Group | 248,672 | $1.0B | 0.47% | |
| 12 | ENGNWenGene Holdings Inc. | 89,702 | $63.4M | 0.03% |